Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Legal Med
2013 Jan 01;1271:145-51. doi: 10.1007/s00414-012-0679-5.
Show Gene links
Show Anatomy links
Cardiac channelopathy causing sudden death as revealed by molecular autopsy.
Kauferstein S
,
Kiehne N
,
Peigneur S
,
Tytgat J
,
Bratzke H
.
???displayArticle.abstract???
Mutations in cardiac ion channel genes have been identified to cause sudden unexplained deaths (SUD), and polymorphisms have also been suggested to be risk factors. Therefore, postmortem genetic testing has become an important tool in elucidating the cause of death.In a sudden death case, a LQT-3-associated mutation (Il768V) in the cardiac sodium channel gene SCN5A was detected beside the common polymorphism H558R which is known to mitigate the effect of mutations in the gene. Both sequence variations were heterozygous. Large number of intervening base pairs make it impossible to identify whether they were located in cis or trans. Functional consequences of both variants were characterized after expressing different cRNAs in Xenopus oocytes by voltage clamp measurements. Western blot analysis indicates that the cis configuration of both variants may lead to a null allele. Since the woman had received an injection of Ultracain®, the potential effect of this drug was tested. In a trans configuration of both variants, the mutant channel exhibited an increase susceptibility of at least 10% for blocking with the drug articaine. Another novel finding is that the midpoint of activation in the case of the mutant channel is leftward shifted of at least -10 mV.The results of the study suggest that postmortem molecular screening is an important tool to elucidate the cause of SUD and that the administration of a drug and a functional interaction between polymorphisms and ion channel mutations may trigger the risk for sudden death.
Ackerman,
Cardiac channelopathies: it's in the genes.
2004, Pubmed
Ackerman,
Cardiac channelopathies: it's in the genes.
2004,
Pubmed
Ackerman,
Molecular autopsy of sudden unexplained death in the young.
2001,
Pubmed
Bradford,
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
1976,
Pubmed
Cheng,
The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current.
2011,
Pubmed
Chugh,
Sudden cardiac death with apparently normal heart.
2000,
Pubmed
Corrado,
Sudden cardiac death in young people with apparently normal heart.
2001,
Pubmed
Daley,
The heart SNPs a beat: polymorphisms in candidate genes for cardiovascular disease.
2001,
Pubmed
Groenewegen,
A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
2003,
Pubmed
,
Xenbase
Hersh,
The pharmacokinetics and cardiovascular effects of high-dose articaine with 1:100,000 and 1:200,000 epinephrine.
2006,
Pubmed
Iwasa,
Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population.
2000,
Pubmed
Laitinen,
Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects.
2000,
Pubmed
Liberthson,
Sudden death from cardiac causes in children and young adults.
1996,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Lu,
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
2006,
Pubmed
,
Xenbase
Maron,
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.
1996,
Pubmed
Morentin,
Sudden unexplained death among persons 1-35 years old.
2003,
Pubmed
Poelzing,
SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene.
2006,
Pubmed
Priori,
Brugada syndrome and sudden cardiac death in children.
2000,
Pubmed
Priori,
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
2002,
Pubmed
Puranik,
Sudden death in the young.
2005,
Pubmed
Rivolta,
A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
2002,
Pubmed
Roses,
Pharmacogenetics and the practice of medicine.
2000,
Pubmed
Saunders,
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
2000,
Pubmed
Splawski,
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
2000,
Pubmed
Tester,
Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
2004,
Pubmed
Tester,
Sudden infant death syndrome: how significant are the cardiac channelopathies?
2005,
Pubmed
Tester,
Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
2007,
Pubmed
Tiso,
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).
2001,
Pubmed
Viswanathan,
A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.
2003,
Pubmed
Wever,
Sudden death in patients without structural heart disease.
2004,
Pubmed
Yang,
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
2002,
Pubmed